E. W. Nivine Levarht

Anti–cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways

Leendert A. Trouw, Elisabeth M. Haisma, E. W. Nivine Levarht et al. · Arthritis & Rheumatism · 2009 · 261 citations

Life Sciences, Immunology, Pathobiology +17

Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis

Jing Shi, Lotte A van de Stadt, E. W. Nivine Levarht et al. · Annals of the Rheumatic Diseases · 2013 · 215 citations

Life Sciences, Immunology, Internal Medicine +17

Brief Report: Anti–Carbamylated Protein Antibodies Are Present in Arthralgia Patients and Predict the Development of Rheumatoid Arthritis

Jing Shi, Lotte A van de Stadt, E. W. Nivine Levarht et al. · Arthritis & Rheumatism · 2012 · 186 citations · Full text

Life Sciences, Immunology, Internal Medicine +14

Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment

Y K Onno Teng, E. W. Nivine Levarht, Mojtaba Hashemi et al. · Arthritis & Rheumatism · 2007 · 169 citations · Full text

Life Sciences, Immunology, Internal Medicine +16

Value of anti–modified citrullinated vimentin and third‐generation anti–cyclic citrullinated peptide compared with second‐generation anti–cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis

M. P. M. van der Linden, Diane van der Woude, Andreea Ioan‐Facsinay et al. · Arthritis & Rheumatism · 2009 · 164 citations · Full text

Life Sciences, Immunology, Internal Medicine +17